1 study found for:    21990397 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients
Conditions: Metastatic Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Intervention: Drug: Bevacizumab and eribulin

Indicates status has not been verified in more than two years